Barrington analyst Michael Petusky downgraded Surmodics (SRDX) to Underperform from Market Perform given that shares are now trading within 3.3% of the GTCR merger offer. The firm thinks investors should consider exiting the position and sees little to no possibility of a higher bid emerging at this point, the analyst tells investors.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRDX:
- SurModics Merger with GTCR LLC Clears Legal Hurdle
- Midday Fly By: SoftBank exits Nvidia, CoreWeave cuts guidance
- Morning Movers: Nvidia dips after SoftBank sells out of stake
- Surmodics confirms District Court denies request for preliminary injunction
- Surmodics acquisition by GTCR can proceed, Reuters reports